tradingkey.logo

MetLife Inc

MET
79.210USD
-0.610-0.76%
Close 11/03, 16:00ETQuotes delayed by 15 min
52.82BMarket Cap
12.91P/E TTM

MetLife Inc

79.210
-0.610-0.76%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of MetLife Inc

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

MetLife Inc's Score

Industry at a Glance

Industry Ranking
8 / 119
Overall Ranking
95 / 4617
Industry
Insurance

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 17 analysts
Buy
Current Rating
94.857
Target Price
+18.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

MetLife Inc Highlights

StrengthsRisks
MetLife, Inc. is a financial services company. The Company is engaged in providing insurance, annuities, employee benefits and asset management for individual and institutional customers. The Company operates through six segments: Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its Group Benefits segment offers life insurance, dental, group short- and long-term disability, individual disability, accidental death and dismemberment (AD&D) insurance, vision, and accident and health insurance, as well as prepaid legal plans and pet insurance. It also sells administrative services-only (ASO) arrangements to some employers. Its RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 36.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.13%.
Fairly Valued
The company’s latest PE is 13.37, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 615.21M shares, decreasing 1.18% quarter-over-quarter.
Held by Van Duyn Dodge & E. Morris Cox
Star Investor Van Duyn Dodge & E. Morris Cox holds 53.18M shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 7.64, which is higher than the Insurance industry's average of 6.51. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 17.39B, representing a year-over-year decrease of 2.53%, while its net profit experienced a year-over-year decrease of 23.46%.

Score

Industry at a Glance

Previous score
7.64
Change
0

Financials

7.39

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

9.43

Operational Efficiency

7.21

Growth Potential

6.01

Shareholder Returns

8.14

MetLife Inc's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 7.40, which is higher than the Insurance industry's average of 7.37. Its current P/E ratio is 13.37, which is 204.38% below the recent high of 40.69 and 36.02% above the recent low of 8.55.

Score

Industry at a Glance

Previous score
7.40
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 8/119
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 8.00, which is higher than the Insurance industry's average of 7.32. The average price target for MetLife Inc is 95.50, with a high of 108.00 and a low of 84.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 17 analysts
Buy
Current Rating
94.857
Target Price
+18.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

19
Total
9
Median
8
Average
Company name
Ratings
Analysts
MetLife Inc
MET
17
Prudential Financial Inc
PRU
17
Corebridge Financial Inc
CRBG
15
Unum Group
UNM
14
Aflac Inc
AFL
14
Lincoln National Corp
LNC
14
1
2
3
4

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 6.44, which is lower than the Insurance industry's average of 6.94. Sideways: Currently, the stock price is trading between the resistance level at 82.66 and the support level at 76.74, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.79
Change
-0.35

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.026
Sell
RSI(14)
47.514
Neutral
STOCH(KDJ)(9,3,3)
62.596
Buy
ATR(14)
1.444
Low Volatility
CCI(14)
18.615
Neutral
Williams %R
74.199
Sell
TRIX(12,20)
-0.121
Sell
StochRSI(14)
62.372
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
79.052
Buy
MA10
78.856
Buy
MA20
79.773
Sell
MA50
80.292
Sell
MA100
79.095
Buy
MA200
79.533
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 10.00, which is higher than the Insurance industry's average of 6.79. The latest institutional shareholding proportion is 92.51%, representing a quarter-over-quarter decrease of 14.04%. The largest institutional shareholder is The Vanguard, holding a total of 64.75M shares, representing 9.74% of shares outstanding, with 16.18% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Metropolitan Life Insurance Co. (US)
108.24M
-1.06%
The Vanguard Group, Inc.
Star Investors
56.89M
-0.49%
53.18M
-1.36%
BlackRock Institutional Trust Company, N.A.
29.43M
-2.91%
State Street Investment Management (US)
26.03M
-2.91%
T. Rowe Price Associates, Inc.
Star Investors
19.38M
-24.39%
Geode Capital Management, L.L.C.
12.83M
-1.16%
Wellington Management Company, LLP
12.39M
-12.13%
Norges Bank Investment Management (NBIM)
9.40M
+5.35%
Pzena Investment Management, LLC
Star Investors
9.14M
+6.84%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 9.49, which is higher than the Insurance industry's average of 6.81. The company's beta value is 0.86. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
9.49
Change
0
Beta vs S&P 500 index
0.86
VaR
+2.69%
240-Day Maximum Drawdown
+22.47%
240-Day Volatility
+28.81%

Return

Best Daily Return
60 days
+3.32%
120 days
+3.32%
5 years
+9.97%
Worst Daily Return
60 days
-4.63%
120 days
-4.63%
5 years
-9.01%
Sharpe Ratio
60 days
+1.50
120 days
-0.08
5 years
+0.60

Risk Assessment

Maximum Drawdown
240 days
+22.47%
3 years
+33.24%
5 years
+36.17%
Return-to-Drawdown Ratio
240 days
-0.22
3 years
+0.11
5 years
+0.31
Skewness
240 days
-0.48
3 years
-0.63
5 years
-0.37

Volatility

Realised Volatility
240 days
+28.81%
5 years
+27.16%
Standardised True Range
240 days
+2.31%
5 years
+1.94%
Downside Risk-Adjusted Return
120 days
-10.31%
240 days
-10.31%
Maximum Daily Upside Volatility
60 days
+11.30%
Maximum Daily Downside Volatility
60 days
+15.72%

Liquidity

Average Turnover Rate
60 days
+0.45%
120 days
+0.49%
5 years
--
Turnover Deviation
20 days
+1.63%
60 days
-6.92%
120 days
+1.62%

Peer Comparison

Insurance
MetLife Inc
MetLife Inc
MET
7.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Essent Group Ltd
Essent Group Ltd
ESNT
8.95 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hci Group Inc
Hci Group Inc
HCI
8.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Renaissancere Holdings Ltd
Renaissancere Holdings Ltd
RNR
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Assured Guaranty Ltd
Assured Guaranty Ltd
AGO
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Arch Capital Group Ltd
Arch Capital Group Ltd
ACGL
8.29 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI